You are here: Industry Insights > VBI Vaccines

News List

VBI Vaccines begins enrolment in Covid-19 vaccine candidate study pharmaceutical-technology
March 11, 2021
VBI Vaccines has commenced enrolment in an adaptive Phase I/II clinical study of its enveloped virus-like particle (eVLP) Covid-19 vaccine candidate, VBI-2902.
Therapure Signs Manufacturing Deal with VBI Vaccines contractpharma
August 19, 2020
For biomanufacturing of coronavirus vaccine candidates as well as the aseptic fill of the drug product.
VBI Vaccines to develop pan-coronavirus vaccine pharmaceutical-technology
April 02, 2020
VBI Vaccines has partnered with the National Research Council of Canada (NRC) to create a pan-coronavirus vaccine candidate.
Brii Biosciences ramps up with VBI Vaccines partnership, new R&D headquarters fiercebiotech
January 02, 2019
Brii Biosciences, a biotech that aims to improve public health in China, launched earlier this year with $260 million in committed capital and a trio of partnerships.....
VBI Vaccines touts positive phase 1 data for CMV vaccine fiercevaccines
May 17, 2018
VBI wants to prevent cytomegalovirus infections in newborns by vaccinating women before pregnancy, a market it says carries blockbuster potential.